Home › Funds › Boxer Capital Management, LLC › AMLX
Boxer Capital Management, LLC position in AMLX
AMYLYX PHARMACEUTICALS INC · Health Care
Boxer Capital Management, LLC reported holding 800,000 shares of AMLX (AMYLYX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$14.4M, representing 1.08% of its reported portfolio and ranking #22 among its reported holdings. Boxer Capital Management, LLC has disclosed AMLX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Boxer Capital Management, LLC's AMLX position evolved
Boxer Capital Management, LLC first disclosed a stake in AMLX in Q4 2024 at 1,750,000 shares (US$6.6M). The position peaked in Q2 2026 at 800,000 shares, worth US$14.4M. Across 7 filings, Boxer Capital Management, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 800,000 shares valued at US$14.4M. Notable position changes include a 30% trim in Q2 2025 (shares rose 112% over the following quarter), a 27% trim in Q3 2025 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 1.75M | $6.62M | New |
| Q1 2025 | 1.75M | $6.20M | Hold |
| Q2 2025 | 1.23M | $7.85M | Reduce |
| Q3 2025 | 900.00K | $12.23M | Reduce |
| Q4 2025 | 800.00K | $9.66M | Reduce |
| Q1 2026 | 800.00K | $11.12M | Hold |
| Q2 2026 | 800.00K | $14.37M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AMLX and 13F data
AMLX (AMYLYX PHARMACEUTICALS INC) is a Health Care company. 50 other funds we track also report a position in AMLX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$149.7M), TCG Crossover Management, LLC (US$112.1M), Commodore Capital LP (US$101.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AMLX
- PERCEPTIVE ADVISORS LLC 8.33M sh · $149.69M · Q2 2026
- TCG Crossover Management, LLC 6.24M sh · $112.14M · Q2 2026
- Commodore Capital LP 5.65M sh · $101.47M · Q2 2026
- Saturn V Capital Management LP 4.62M sh · $83.05M · Q2 2026
- First Light Asset Management, LLC 3.02M sh · $54.30M · Q2 2026
- Siren, L.L.C. 1.48M sh · $26.59M · Q2 2026
- Almitas Capital LLC 974.88K sh · $17.51M · Q2 2026
- Jones Hill Capital LP 894.06K sh · $16.06M · Q2 2026
- GREAT POINT PARTNERS LLC 700.00K sh · $12.57M · Q2 2026
- Parkman Healthcare Partners LLC 398.78K sh · $7.16M · Q2 2026
- HighVista Strategies LLC 386.08K sh · $6.93M · Q2 2026
- STEMPOINT CAPITAL LP 384.30K sh · $6.90M · Q2 2026
More on Boxer Capital Management, LLC
FAQ
How long has Boxer Capital Management, LLC held AMLX?
Boxer Capital Management, LLC has disclosed AMLX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Boxer Capital Management, LLC's current position in AMLX?
As of Q2 2026, Boxer Capital Management, LLC holds 800.00K shares of AMLX (AMYLYX PHARMACEUTICALS INC), valued at $14.37M, representing 1.08% of its reported portfolio and ranking #22.
Has Boxer Capital Management, LLC been buying or selling AMLX?
In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC held unchanged its position in AMLX. The position peaked in Q2 2026 at 800.00K shares.
Which other funds hold AMLX?
Other major institutional holders of AMLX include PERCEPTIVE ADVISORS LLC, TCG Crossover Management, LLC, Commodore Capital LP, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.